(Q43690865)

25 November 2017

title

The IL-6 receptor antagonist SANT-7 overcomes bone marrow stromal cell-mediated drug resistance of multiple myeloma cells (English)

1 reference

25 November 2017

main subject

multiple drug resistance

1 reference

1 reference

R Savino

3

0 references

author name string

D Hönemann

1

1 reference

25 November 2017

M Chatterjee

2

1 reference

25 November 2017

K Bommert

4

1 reference

25 November 2017

R Burger

5

1 reference

25 November 2017

M Gramatzki

6

1 reference

25 November 2017

B Dörken

7

1 reference

25 November 2017

R C Bargou

8

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

International Journal of Cancer

25 November 2017

published in

1 reference

25 November 2017

volume

93

1 reference

25 November 2017

issue

5

1 reference

25 November 2017

page(s)

674-680

1 reference

Bone marrow microenvironment and the progression of multiple myeloma

25 November 2017

cites work

1 reference

Syndecan-1 (CD 138) in myeloma and lymphoid malignancies: a multifunctional regulator of cell behavior within the tumor microenvironment

21 January 2018

1 reference

Interleukin 6 is essential for in vivo development of B lineage neoplasms

21 January 2018

1 reference

Impaired immune and acute-phase responses in interleukin-6-deficient mice.

21 January 2018

1 reference

The critical role of interleukin-6, interleukin-1B and macrophage colony-stimulating factor in the pathogenesis of bone lesions in multiple myeloma

21 January 2018

1 reference

Marrow stromal cells as stem cells for nonhematopoietic tissues

21 January 2018

1 reference

A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay

21 January 2018

1 reference

The myeloma cell antigen syndecan-1 is lost by apoptotic myeloma cells

21 January 2018

1 reference

Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130

21 January 2018

1 reference

Oncostatin M, leukemia inhibitory factor, and interleukin 6 induce the proliferation of human plasmacytoma cells via the common signal transducer, gp130.

21 January 2018

1 reference

Chimaeric anti-interleukin 6 monoclonal antibodies in the treatment of advanced multiple myeloma: a phase I dose-escalating study

21 January 2018

1 reference

CD44 isoforms distinguish between bone marrow plasma cells from normal individuals and patients with multiple myeloma at different stages of disease

21 January 2018

1 reference

Interdependence between cytokines and cell adhesion molecules to induce interleukin-6 production by stromal cells in myeloma

21 January 2018

1 reference

Dexamethasone plus retinoids decrease IL-6/IL-6 receptor and induce apoptosis in myeloma cells

21 January 2018

1 reference

A New Type of Cytokine Receptor Antagonist Directly Targeting gp130

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.1388

1 reference

25 November 2017

1 reference